(Q43762912)

English

Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Iwaniec UT

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Samnegård E

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cullen DM

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kimmel DB

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

352-360

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid determination of cancellous bone mineral loss in ovariectomized rats by a subtraction technique

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of nicotine on bone and calciotropic hormones in growing female rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clodronate treatment on established bone loss in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alendronate treatment for osteoporosis: a review of the clinical evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of ovariectomy and aging on the rat skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1-34) administration

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900582-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S8756-3282(01)00582-8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43762912&oldid=2103123855"